aiqbench analysis
This article focuses on Colossal Biosciences' de-extinction efforts, which rely heavily on computational biology platforms like Form Bio and AI-driven predictive modeling tools such as Astromech to analyze genetic material from fossils. While the broader context involves deep-tech sectors, the core technological drivers enabling these biological breakthroughs are machine learning algorithms for genome reconstruction and simulation, making this relevant to our coverage of applied ML in life sciences.
Colossal Biosciences reportedly in talks to raise new capital at $20B–$30B valuation

The de-extinction startup is looking to double or triple its previous valuation, according to the report.
When de-extinction startup Colossal Biosciences revealed last year that it was attempting to “resurrect” the dire wolf from genetic material found in fossils, we argued that, despite the controversy surrounding…
Excerpt shown under the publisher's RSS terms · 30 words · full text and figures are on the publisher's site
Related coverage

Elon Musk is steamrolling Wall Street to become a trillionaire
The Verge · Jun 4, 2026

News
Quantum Computing Report · Jun 7, 2026
People might start believing in radical life extension soon
LessWrong · Jul 20, 2026

Saudi’s economic transformation collides with war and falling FDI
Fortune · Oct 7, 2026